Raltegravir blocks the infectivity of red-fluorescent-protein (mCherry)-labeled HIV-1JR-FL in the setting of post-exposure prophylaxis in NOD/SCID/Jak3−/− mice transplanted with human PBMCs-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Raltegravir blocks the infectivity of red-fluorescent-protein (mCherry)-labeled HIV-1JR-FL in the setting of post-exposure prophylaxis in NOD/SCID/Jak3−/− mice transplanted with human PBMCs

Published:2018-01 Issue: Volume:149 Page:78-88
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Ogata-Aoki Hiromi,Higashi-Kuwata Nobuyo,Hattori Shin-ichiro,Hayashi Hironori,Danish Matthew,Aoki Manabu,Shiotsu Chiemi,Hashiguchi Yumi,Hamada Akinobu,Kobayashi Hisataka,Ihn Hironobu,Okada Seiji,Mitsuya Hiroaki

Funder

Japan Agency for Medical Research and Development

JSPS

National Center for Global Health & Medicine

Center for Cancer Research

National Cancer Institute, National Institutes of Health

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference29 articles.

1. Molecular probes for the in vivo imaging of cancer;Alford;Mol. Biosyst.,2009

2. HIV-associated multinucleated giant cells in lymphoid tissue of the Waldeyer's ring: a detailed study;Dargent;Mod. Pathol.,2000

3. Systemic administration of antiretrovirals prior to exposure prevents rectal and intravenous HIV-1 transmission in humanized BLT mice;Denton;PLoS One,2010

4. PCR-mediated recombination: a general method applied to construct chimeric infectious molecular clones of plasma-derived HIV-1 RNA;Fang;Nat. Med.,1999

5. Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir;Garcia-Lerma;PLoS Med.,2008

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP